Michael Gertner is listed as an executive officer and director on 14 SEC Form D filings by 3 issuers between Apr 2009 and Sep 2015: Kona Medical, Inc. (Bellevue, WA — biotechnology — 2010–2015; $30M reported sold to 17 investors), ORAYA THERAPEUTICS INC (Newark, CA — other technology — 2009–2014; $25.1M reported sold to 7 investors) and Nellix Inc (Palo Alto, CA — industry reported as "Other" — 2009–2010; $11.7M reported sold to 15 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $66.8M sold in total.
Listed alongside Peter Cohn (10 shared filings), Brian Halak (9 shared filings), Guido Neels (6 shared filings), Immanuel Thangaraj (5 shared filings), Louis Cannon (5 shared filings) and 12 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 14 public filings for Michael Gertner and found 9 differences: Form D filed 31 days after the first sale; Form D filed 20 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.